CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-03-02 | FICKLING ROY H Director | Grant or award | +1,209 | $0.62 | $750 | 63,772 |
| 2009-02-18 | SHIEBLER WILLIAM N Director | Grant or award | +641 | $0.78 | $500 | 107,563 |
| 2009-02-18 | LAFFER ARTHUR B Director | Grant or award | +641 | $0.78 | $500 | 312,703 |
| 2009-02-18 | FICKLING ROY H Director | Grant or award | +641 | $0.78 | $500 | 62,563 |
| 2009-01-20 | SHIEBLER WILLIAM N Director | Grant or award | +1,922 | $0.65 | $1K | 106,922 |
| 2009-01-20 | Schwieterman William D Director | Grant or award | +1,153 | $0.65 | $749 | 41,153 |
| 2009-01-20 | LAFFER ARTHUR B Director | Grant or award | +1,922 | $0.65 | $1K | 312,062 |
| 2009-01-20 | FICKLING ROY H Director | Grant or award | +1,922 | $0.65 | $1K | 61,922 |
| 2009-01-20 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2009-01-20 | MURPHY JAMES B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2009-01-20 | Walicke Patricia A. VP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2009-01-20 | Kollins John A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2008-12-30 | Symphony Capital Partners LP Director | Option exercise | +11,281,877 | $1.11 | $12.5M | 17,117,118 |
| 2008-12-30 | Symphony Capital Partners LP Director | Option exercise · Common Stock Warrant (right to buy) | −11,281,877 | 0 | ||
| 2008-12-30 | SHIEBLER WILLIAM N Director | Gift | −60,000 | 105,000 | ||
| 2008-12-30 | SHIEBLER WILLIAM N Director | Gift | +60,000 | 81,000 | ||
| 2008-12-29 | SHIEBLER WILLIAM N Director | Gift | −21,000 | 165,000 | ||
| 2008-12-29 | SHIEBLER WILLIAM N Director | Gift | +21,000 | 21,000 | ||
| 2008-12-16 | Kollins John A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2008-01-11 | Chin Richard President and CEO | Grant or award | +36,610 | 392,074 |
Page 13 of 17 · 340 trades